AAPG Ascentage Pharma Group International

NASDAQ
$17.00

Ascentage Pharma Group International (AAPG) is confirmed to report earnings on August 19, 2026, before the market open. The consensus earnings estimate is a loss of $0.44 per share.

Earnings Date
2nd Quarter, Jun 2026
Aug 19
Wednesday · Before Open
Earnings Whisper
-
vs ($0.44)
Rev est $24.07M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Ascentage Pharma Group International

Ascentage Pharma is an integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address unmet medical needs primarily in hematological malignancies. Ascentage Pharma is based in ROCKVILLE, Md.

Sector

Healthcare

Industry

Biotechnology